Pharmaceutical industry on recovery track

Published: 2003-12-01 07:00:00

Updated: 2003-12-01 07:00:00

Amid deepened business slump, overall pharmaceutical business condition has improved after the third quarter of this year and leading domestic pharmaceutical firms are grappling with their lackluster sales via aggressive marketing of flagship products and new drug launchings.

Pharmaceutical b...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK